139 related articles for article (PubMed ID: 10036601)
1. Use of intrauterine contraceptive devices in nulliparous women: personal experience over a 12-year period.
Lete I; Morales P; de Pablo JL
Eur J Contracept Reprod Health Care; 1998 Dec; 3(4):190-3. PubMed ID: 10036601
[TBL] [Abstract][Full Text] [Related]
2. A review of the use of intrauterine devices in nulliparous women.
Graham S; Simcock BW
Contraception; 1982 Oct; 26(4):323-46. PubMed ID: 6759026
[TBL] [Abstract][Full Text] [Related]
3. Complications of the intrauterine device in nulliparous and parous women.
Veldhuis HM; Vos AG; Lagro-Janssen AL
Eur J Gen Pract; 2004 Sep; 10(3):82-7. PubMed ID: 15534571
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine devices in nulliparous women.
Petersen KR; Brooks L; Jacobsen B; Skouby SO
Adv Contracept; 1991 Dec; 7(4):333-8. PubMed ID: 1776557
[TBL] [Abstract][Full Text] [Related]
5. Postpartum IUDS: keys for success.
O'Hanley K; Huber DH
Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
[TBL] [Abstract][Full Text] [Related]
6. Five years private practice experience of nulliparous women using copper IUD's.
Smith RP; Goresky DM; Etchell DM
Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354
[TBL] [Abstract][Full Text] [Related]
7. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
8. Adolescent experience with intrauterine device insertion and use: a retrospective cohort study.
Bayer LL; Jensen JT; Li H; Nichols MD; Bednarek PH
Contraception; 2012 Nov; 86(5):443-51. PubMed ID: 22560185
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with LEM, an intrauterine contraceptive device.
Lane ME; Sindhupak S; Sobrero AJ; Kohli KL
Fertil Steril; 1974 Jul; 25(7):562-8. PubMed ID: 4842755
[TBL] [Abstract][Full Text] [Related]
10. A national study to monitor the safety of IUCD use.
Richardson A; Paul C
Contraception; 1993 Apr; 47(4):359-66. PubMed ID: 8508665
[TBL] [Abstract][Full Text] [Related]
11. Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries.
Farr G; Amatya R; Acosta M; Ekwempu C; Kisninci H
Contraception; 1995 Jul; 52(1):17-22. PubMed ID: 8521710
[TBL] [Abstract][Full Text] [Related]
12. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
[TBL] [Abstract][Full Text] [Related]
13. Copper IUDs, PID, and fertility in nulliparous women.
Struthers BJ
Adv Contracept; 1991; 7(2-3):211-30. PubMed ID: 1950720
[TBL] [Abstract][Full Text] [Related]
14. Was the Dalkon Shield a safe and effective intrauterine device? The conflict between case-control and clinical trial study findings.
Mumford SD; Kessel E
Fertil Steril; 1992 Jun; 57(6):1151-76. PubMed ID: 1601137
[TBL] [Abstract][Full Text] [Related]
15. Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
Wildemeersch D; Goldstuck ND; Jackers G
Gynecol Endocrinol; 2017 Mar; 33(3):223-226. PubMed ID: 28084114
[TBL] [Abstract][Full Text] [Related]
16. Return to fertility in nulliparous and parous women after removal of the GyneFix intrauterine contraceptive system.
Delbarge W; Bátár I; Bafort M; Bonnivert J; Colmant C; Dhont M; Fonzé V; Gevers R; Janssens D; Lavalley P; Salmin E; Degueldre M; Vrijens M; Van Kets H; Wildemeersch D
Eur J Contracept Reprod Health Care; 2002 Mar; 7(1):24-30. PubMed ID: 12041861
[TBL] [Abstract][Full Text] [Related]
17. The acceptability of using IUDs among Egyptian nulliparous women: a cross-sectional study.
Elkhateeb RR; Kishk E; Sanad A; Bahaa H; Hagazy AR; Shaheen K; Moustafa E; Fares H; Gomaa K; Mahran A
BMC Womens Health; 2020 Jun; 20(1):117. PubMed ID: 32503576
[TBL] [Abstract][Full Text] [Related]
18. A study of the copper T intrauterine contraceptive device (TCu 200) in nulliparous women.
Mishell DR; Israel R; Freid N
Am J Obstet Gynecol; 1973 Aug; 116(8):1092-6. PubMed ID: 4721138
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use.
Buchan H; Villard-Mackintosh L; Vessey M; Yeates D; McPherson K
Br J Obstet Gynaecol; 1990 Sep; 97(9):780-8. PubMed ID: 2242362
[TBL] [Abstract][Full Text] [Related]
20. Copper intrauterine device use by nulliparous women: review of side effects.
Hubacher D
Contraception; 2007 Jun; 75(6 Suppl):S8-11. PubMed ID: 17531622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
